CompletedPhase 3NCT00685958

Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery

Studying Body integrity dysphoria

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sanofi
Principal Investigator: ICD CSD
Sanofi
Intervention: enoxaparin (XRP4563)(drug)
Enrollment: 54 target
Eligibility: 20 years · All sexes
Timeline: 2006 – 2007

Study locations (1)

Sanofi- Aventis Administrative Office, Tokyo, Japan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00685958 on ClinicalTrials.gov

Other trials for Body integrity dysphoria

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT06898905
Hyperfractionated Dual Equivalent Fractionated Radiation Therapy
Yale University
RECRUITINGPHASE1NCT06966388
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
Virginia Commonwealth University
RECRUITINGPHASE1, PHASE2NCT06853015
Double Dose 4-AP on Functional Recovery After Spinal Cord Injury
Shirley Ryan AbilityLab
ACTIVE NOT RECRUITINGPHASE3NCT05456425
A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium
Cloudbreak Therapeutics, LLC

See all trials for Body integrity dysphoria →

← Back to all trials